Metrizamide, the new water-soluble non-ionic contrast medium for myelography. Clinical experience.
A survey is made of the development of water-soluble contrast media and of the experimental and preliminary clinical investigations of the new water-soluble contrast medium metrizamide. The experiences with the medium indicate that its use in the subarachnoid space is safe and reliable.
D000818:Animals; D003287:Contrast Media / Q000633:toxicity; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000000981:diagnostic imaging; D008793:Metrizamide / Q000633:toxicity; D009192:Myelography; D009362:Neoplasm Metastasis; D009442:Neurilemmoma / Q000000981:diagnostic imaging; D013120:Spinal Cord Neoplasms / Q000000981:diagnostic imaging; D013125:Spinal Neoplasms / Q000000981:diagnostic imaging
D003287:Contrast Media; D008793:Metrizamide